Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Taste the World: Five Food sources That Have Dazzled Worldwide Palates - 2The World's Dazzling Regular Miracles
- 3Scientists solve the mystery of the prehistoric 'Burtele Foot'
- 4The Benefits of Effective money management for Your Youngsters' Future Monetary Prosperity
- 510 Activities to Lift Your Consume and Bust Your Stomach
- Trying to improve your health and wellness in 2026? Keep it simple
- Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- Instructions to Pick the Ideal SUV Size for Seniors
- Party Urban areas of the World
- Witness the elegance of the cosmic butterfly in a remarkable telescope photo
- Yemen's Houthis ready to join Iran war if needed, raising new shipping risk
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
- 6 Top of the line Lodgings All over The Planet, Which One Do You Concur With
